RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
9.81
+0.02 (0.20%)
At close: Jan 16, 2026, 4:00 PM EST
9.62
-0.19 (-1.94%)
After-hours: Jan 16, 2026, 7:44 PM EST
RxSight Stock Forecast
Stock Price Forecast
The 10 analysts that cover RxSight stock have a consensus rating of "Hold" and an average price target of $11.3, which forecasts a 15.19% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $28.
Price Target: $11.3 (+15.19%)
Analyst Consensus: Hold
* Price targets were last updated on Dec 2, 2025.
Analyst Ratings
The average analyst rating for RxSight stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 8 | 8 | 8 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | +1.94% | Dec 2, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -8.26% | Nov 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | +1.94% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +22.32% | Nov 6, 2025 |
| UBS | UBS | Hold Maintains $16 → $8 | Hold | Maintains | $16 → $8 | -18.45% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
132.27M
from 139.93M
Decreased by -5.47%
Revenue Next Year
137.72M
from 132.27M
Increased by 4.12%
EPS This Year
-1.09
from -0.71
EPS Next Year
-1.01
from -1.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 141.2M | 152.4M | ||
| Avg | 132.3M | 137.7M | ||
| Low | 125.0M | 127.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.9% | 15.2% | ||
| Avg | -5.5% | 4.1% | ||
| Low | -10.6% | -3.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.08 | -0.28 | ||
| Avg | -1.09 | -1.01 | ||
| Low | -1.09 | -1.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.